Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants

Analysis of fecal samples of a subset of infants from a randomized open label trial to determine the effects of supplementing the probiotic Bifidobacterium longum subsp. infantis for the first 21 days finds 40d old control infants exhibit chronic enteric inflammation, which is significantly different from infants colonized with B. infantis EVC001.